Filing exhibits
- 8-K Current report
- 1.1 Underwriting Agreement Relating to the Common Stock
- 1.2 Underwriting Agreement Relating to the Mandatory Convertible Preferred Stock
- 3.1 Certificate of Designations
- 5.1 Opinion of Shearman and Sterling LLP Regarding the Legality of the Shares of Common Stock
- 5.2 Opinion of Shearman and Sterling LLP Regarding the Legality of the Shares of Mandatory Convertible Preferred Stock
- 99.1 Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock
- Download Excel data file
- View Excel data file
Table of Contents